Inhibition of Tumor Growth and Metastasis by Newcastle Disease Virus Strain P05 in a Breast Cancer Mouse Model
/in Breast Cancer, International Publications, Newcastle Disease Virus /von 2023-02-17 / J Breast Cancer 2023 Apr;26(2):186-200Individualized Multimodal Immunotherapy for Adults with IDH1 Wild-Type GBM: A Single Institute Experience
/in Dendritic Cells, Glioblastoma, International Publications, IOZK Veröffentlichungen /von 2023-02-13 / Cancers (Basel) 2023 Feb;15(4)Immunotherapy in breast cancer: an overview of current strategies and perspectives
/in Breast Cancer, International Publications /von 2023-02-13 / NPJ Breast Cancer 2023 Feb;9(1):7Tumor cell vaccine combined with Newcastle disease virus promote immunotherapy of lung cancer
/in International Publications, Newcastle Disease Virus, NSCLC /von 2023-02-01 / J Med Virol 2023 Feb;95(2):e28554
IMMUN-ONKOLOGISCHES ZENTRUM KÖLN
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Das IOZK
Die IOZK Immuntherapie
Aktuelles und Int. Publikationen
- Recent developments in targeting breast cancer stem cells (BCSCs): a descriptive review of therapeutic strategies and emerging therapies
- Neoantigen-targeted dendritic cell vaccination in lung cancer patients induces long-lived T cells exhibiting the full differentiation spectrum
- Individualized Multimodal Immunotherapy (IMI): Scientific Rationale and Clinical Experience from a Single Institution